BSX 6.06 -0.04 / Boston Scientific Corp. BSX 6.06 -0.04 / Boston Scientific Corp. Analyst Ratings | Benzinga

Monday, May 14, 2012

UPDATE: Citigroup Reiterates Neutral Rating, Raises PT for Boston Scientific (Analyst Color, BSX, Price Target, Reiteration, Analyst Ratings / Mon, 11:33am)

Thursday, February 02, 2012

Financial Breakfast: Morning News Summary for February 2, 2012 (BSX, CRM, DELL, DOW, Earnings, MRK, News, SAP, SFSF, STLD, STX, VIA, Futures, Guidance, Upgrades, Commodities, Downgrades, Forex, Technicals, Events, Global, Econ #s, Economics, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, General / Thu, 08:27am)

Tuesday, January 17, 2012

Piper Jaffray Gives Insight to Medical Technology Industry Overview (Analyst Color, ATRC, BSX, MDT, STJ, Price Target, Reiteration, Analyst Ratings / Tue, 10:48am)

Thursday, December 22, 2011

Benzinga's Top Downgrades (AGU, BSX, MANH, VVUS, Downgrades, Analyst Ratings / Thu, 08:31am)
Mizuho Downgrades Boston Scientific to Neutral (BSX, Downgrades, Price Target, Pre-Market Outlook, Analyst Ratings / Thu, 08:15am)

Wednesday, November 23, 2011

Stifel Nicolaus Reiterates Buy, $8 Target on Boston Scientific, Raises Estimates (Analyst Color, BSX, Reiteration, Analyst Ratings / Wed, 12:23pm)
UPDATE: Citi Lowers PT to $5.70 on Boston Scientific (Analyst Color, BSX, News, Price Target, FDA, Analyst Ratings / Wed, 11:05am)
Jefferies Maintains Hold Rating and $6.50 PT on Boston Scientific (Analyst Color, BSX, Reiteration, Pre-Market Outlook, Analyst Ratings / Wed, 10:25am)
Goldman Sachs Maintains Neutral Rating and $5.80 PT on Boston Scientific (Analyst Color, BSX, News, Reiteration, FDA, Pre-Market Outlook, Analyst Ratings / Wed, 10:14am)
Citigroup Lowers PT on Boston Scientific to $5.70 (BSX, Price Target, Pre-Market Outlook, Analyst Ratings / Wed, 09:51am)
Morgan Stanley Reiterates Equal-Weight on Boston Scientific (Analyst Color, BSX, News, Reiteration, FDA, Pre-Market Outlook, Analyst Ratings / Wed, 08:54am)
Bank of America Maintains Neutral Rating and $8.50 PT on Boston Scientific (Analyst Color, BSX, LSC, News, Reiteration, FDA, Pre-Market Outlook, Analyst Ratings / Wed, 08:51am)
Brean Murray Carret & Co Maintains Hold Rating on Boston Scientific (Analyst Color, BSX, News, Reiteration, FDA, Pre-Market Outlook, Analyst Ratings / Wed, 08:44am)
UPDATE: Piper Jaffray Reiterates Neutral, Ups Target to $7 on Boston Scientific (Analyst Color, BSX, News, Price Target, FDA, Pre-Market Outlook, Analyst Ratings / Wed, 08:18am)
Oppenheimer Reiterates Perform on Boston Scientific (Analyst Color, BSX, Reiteration, Pre-Market Outlook, Analyst Ratings / Wed, 08:00am)
FDA Approves PROMUS for Boston Scientific, Deutsche Bank Maintains Hold (Analyst Color, BSX, News, Reiteration, FDA, Pre-Market Outlook, Analyst Ratings / Wed, 07:23am)
Piper Jaffray Lowers PT on Boston Scientific to $6 (BSX, Price Target, Analyst Ratings / Wed, 06:54am)

Monday, November 14, 2011

BofA/ML Reiterates Buy Rating on Blackstone Group (Analyst Color, BSX, Price Target, Reiteration, Analyst Ratings / Mon, 02:12pm)
JP Morgan Lowers EPS Estimates on Boston Scientific (Analyst Color, BSX, Reiteration, Analyst Ratings / Mon, 09:26am)
Morgan Stanley Maintains Equal-Weight Rating on Boston Scientific (Analyst Color, BSX, Reiteration, Analyst Ratings / Mon, 07:52am)

Tuesday, November 08, 2011

End-of-Day Market Summary for November 8, 2011 (ATVI, BSX, CBOU, HON, News, NILE, OVTI, QNST, SLXP, STJ, SZYM, TRAK, TRGT, TTWO, WMS, WTW, YPF, Broad U.S. Equity ETFs, Upgrades, Downgrades, Events, Global, Econ #s, Economics, Hot, After-Hours Center, Markets, Analyst Ratings, Movers, Tech, Reviews, ETFs / Tue, 05:14pm)

Thursday, November 03, 2011

Credit Suisse Initiating Coverage on Boston Scientific (Analyst Color, BSX, Price Target, Initiation, Analyst Ratings / Thu, 09:06am)

Friday, October 21, 2011

Gabelli Has Hold on Boston Scientific (Analyst Color, BSX, Price Target, Analyst Ratings / Fri, 08:54am)
UPDATE: Piper Jaffray Lowers PT to $7 on Boston Scientific (Analyst Color, BSX, Earnings, News, Price Target, Analyst Ratings / Fri, 08:27am)
Morgan Stanley Maintains Equal-Weight Rating on Boston Scientific (Analyst Color, BSX, Reiteration, Analyst Ratings / Fri, 08:03am)
UPDATE: J.P. Morgan Lowers Price Target on Boston Scientific to $7 (Analyst Color, BSX, Price Target, Analyst Ratings / Fri, 07:57am)
Morgan Keegan Market Perform on Boston Scientific (Analyst Color, BSX, Price Target, Analyst Ratings / Fri, 07:48am)

Tuesday, October 18, 2011

Piper Jaffray Maintains Neutral Rating and $7.50 PT on Boston Scientific (Analyst Color, BSX, Reiteration, Analyst Ratings / Tue, 07:53am)

Monday, October 10, 2011

Oppenheimer Publishes Industry Update on Large-Cap Medtech (Analyst Color, BSX, MDT, STJ, SYK, Analyst Ratings / Mon, 10:02am)

Wednesday, September 14, 2011

Piper Jaffray Maintains Boston Scientific Neutral, $7.50 PT (Analyst Color, BSX, Analyst Ratings / Wed, 07:58am)
Oppenheimer Comments on Boston Scientific (Analyst Color, BSX, Analyst Ratings / Wed, 07:53am)

Wednesday, August 24, 2011

Benzinga's Top Downgrades (ABT, BSX, PSUN, UTHR, Downgrades, Analyst Ratings / Wed, 07:49am)
Morgan Keegan Downgrades Boston Scientific To Market Perform, Lowers PT To $7 (BSX, Downgrades, Price Target, Analyst Ratings / Wed, 06:09am)

Friday, July 29, 2011

Morgan Keegan Reports Good Quarter For Boston Scientific (Analyst Color, BSX, Analyst Ratings / Fri, 09:32am)
UPDATE: Citi Lowers PT on Boston Scientific to $7.30 (Analyst Color, BSX, Price Target, Analyst Ratings / Fri, 08:08am)
J.P. Morgan Underweight On Boston Scientific Corporation (Analyst Color, BSX, Price Target, Analyst Ratings / Fri, 07:37am)